Ozobax DS 10 MG per 5 mL Oral Solution
- RxCUI
- 2667943
- RxNorm name
- Ozobax DS 10 MG per 5 mL Oral Solution
- Display name
- Ozobax DS 10 MG per 5 mL Oral Solution
- Full name
- Ozobax DS 10 MG per 5 mL Oral Solution
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:23
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OZOBAX DS | BACLOFEN | Rosemont Pharmaceuticals LLC | d8ddcec5-debe-42b4-a803-e65917cc6a54 | 2026-03-13 | Warnings, Adverse reactions | 2667943 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d8ddcec5-debe-42b4-a803-e65917cc6a54 | OZOBAX DS 10 MG in 5 mL Oral Solution [PSN] · baclofen 2 MG/ML Oral Solution [Ozobax] [SBD] · Ozobax DS 10 MG per 5 mL Oral Solution [SY] | 3 | 2 | These highlights do not include all the information needed to use OZOBAX ® DS safely and effectively. See full prescribing information for OZOBAX DS. OZOBAX DS (baclofen) oral solution Initial U.S. Approval: 1977 | 20260313 |